massiv
parallel
sequenc
allow
rapid
lowcost
deep
sequenc
viral
genom
provid
opportun
gain
greater
insight
viral
evolut
fit
emerg
transmiss
current
revers
transcript
follow
polymeras
chain
reaction
rtpcr
primer
design
amplifi
specif
viral
rna
sequenc
common
method
amplifi
rna
virus
prior
sequenc
downstream
applic
recent
studi
use
newman
et
al
manuscript
submit
illumina
sequenc
rtpcr
amplicon
rna
virus
howev
standard
rtpcr
method
adequ
gener
templat
suitabl
sequenc
lowcopi
viral
rna
sampl
laborintens
method
nest
pcr
singlegenom
amplif
sga
typic
requir
exampl
lowcopi
viral
rna
sampl
includ
follow
hiv
control
capabl
control
viru
absenc
antiretrovir
therapi
dengu
viru
denv
clinic
sampl
collect
peak
viremia
west
nile
viru
wnv
surveil
sampl
obtain
genom
sequenc
sampl
provid
valuabl
insight
viral
attenu
respons
host
immun
pressur
drug
treatment
infect
diseas
sever
transmiss
epidem
spread
develop
highthroughput
method
viral
sequenc
lowcopi
viral
sampl
present
challeng
first
method
robust
gener
suffici
materi
sequenc
librari
second
broadli
applic
varieti
sampl
type
final
consist
gener
sequenc
coverag
entir
target
region
typic
protein
code
region
cd
viral
genom
sequenceindepend
method
attract
sequenc
viral
genom
reli
prior
viral
sequenc
knowledg
allow
sequenc
viral
genom
littl
genom
inform
highli
diverg
virus
robust
primer
target
conserv
region
difficult
design
date
method
difficulti
sequenc
complet
genom
clinic
sampl
due
high
level
host
contamin
low
viral
amount
sispa
method
describ
djikeng
et
al
capabl
captur
complet
genom
viral
rna
sampl
requir
high
viral
amount
remov
host
rna
contamin
rnase
prior
viral
rna
extract
work
victoria
et
al
demonstr
abil
captur
complet
genom
stool
sampl
appear
sampl
high
viral
titer
recent
work
ninomiya
et
al
demonstr
success
captur
hepat
c
viru
hcv
total
rna
sequenc
clinic
sampl
method
requir
ng
input
rna
exce
amount
typic
present
clinic
sampl
moor
et
al
evalu
sensit
detect
infecti
agent
use
rna
sequenc
method
work
well
detect
low
amount
viru
limit
input
amount
copi
viral
rna
per
sampl
studi
evalu
use
sequenceindepend
rna
amplif
method
nugen
ovat
rnaseq
system
captur
complet
target
region
viral
genom
lowcopi
hiv
respiratori
syncyti
viru
rsv
wnv
sampl
previous
amplif
method
use
cellular
transcriptom
analysi
input
amount
pg
ng
total
rna
use
femtogram
attogram
viral
rna
amplif
method
combin
illumina
sequenc
de
novo
assembl
viral
read
success
gener
consensu
sequenc
complet
nearli
complet
cd
viral
genom
plasma
sampl
chronic
infect
subject
obtain
ragon
institut
mgh
mit
harvard
boston
subject
gave
written
inform
consent
studi
approv
massachusett
gener
hospit
review
board
viru
stock
produc
transfect
cell
atcc
manassa
va
plasmid
dna
encod
fulllength
infecti
hiv
rna
use
polyfect
transfect
reagent
qiagen
valencia
ca
accord
modifi
manufactur
protocol
briefli
day
prior
transfect
cell
seed
flask
transfect
plasmid
dna
minimum
concentr
dilut
final
volum
dulbecco
modifi
eagl
medium
without
supplement
polyfect
reagent
ad
solut
mix
gentl
pipet
incub
min
room
temperatur
incub
medium
remov
cell
transfect
follow
singl
wash
cold
phosphatebuff
salin
pb
ml
fresh
medium
ad
incub
transfect
mixtur
transfer
flask
swirl
gentli
mix
incub
hour
medium
remov
discard
cell
wash
cold
pb
ml
fresh
medium
ad
return
cell
incub
transfect
supernat
harvest
hour
filter
filter
store
aliquot
viral
titer
determin
antigen
enzymelink
immunosorb
assay
perkinelm
waltham
per
manufactur
protocol
wnv
produc
infecti
cdna
clone
accord
method
describ
elsewher
briefli
hamster
cell
atcc
transfect
transmesseng
qiagen
rna
transcrib
vitro
pflwnv
use
mmessag
mmachin
kit
life
technolog
carlsbad
ca
cell
inspect
daili
viru
harvest
approxim
day
replic
viruscontain
tissu
cultur
supernat
supplement
fb
store
ml
aliquot
use
without
subsequ
passag
nasal
wash
collect
studi
team
member
use
similarli
quantifiedcollect
method
previous
describ
studi
conduct
approv
univers
tennesse
institut
review
board
includ
appropri
inform
consent
compli
relev
feder
guidelin
institut
polici
hiv
clinic
sampl
ml
plasma
thaw
centrifug
min
remov
cellular
debri
hiv
wnv
clone
sampl
cell
cultur
supernat
use
extract
sampl
brought
volum
pb
centrifug
hour
pellet
resuspend
pb
use
input
viral
rna
extract
rsv
clinic
sampl
nasal
aspir
use
extract
without
centrifug
step
viral
rna
isol
use
qiaamp
viral
rna
mini
kit
qiagen
per
manufactur
protocol
except
linear
polyacrylamid
life
technolog
use
carrier
instead
carrier
rna
provid
kit
viral
rna
elut
ave
buffer
aliquot
store
viral
sampl
treat
turbo
dnase
life
technolog
use
manufactur
rigor
treatment
ensur
remov
dna
hiv
sampl
quantit
rtpcr
qrtpcr
use
measur
number
copi
hiv
experi
perform
abi
life
technolog
use
gag
agtggggggacatcaagcagccatgcaaat
tgctatgtcacttccccttggttctct
primer
nm
final
concentr
superscript
iii
platinum
sybr
green
onestep
qrtpcr
kit
life
technolog
per
manufactur
protocol
quantif
standard
consist
linear
plasmid
similarli
hiv
number
wnv
copi
sampl
also
quantifi
qrtpcr
perform
abi
use
forward
primer
tcagcgatctctccaccaaag
revers
primer
gggtcagcacgtttgtcattg
probe
famtgcccgaccatgggagaagctctamra
superscript
iii
platinum
onestep
qrtpcr
kit
life
technolog
per
manufactur
protocol
previous
describ
method
addit
number
rsv
copi
sampl
also
quantifi
qrtpcr
perform
abi
use
forward
primer
catccagcaaatacaccatcca
revers
primer
ttctgcacatcataattaggagtatcaa
probe
famcggagcacaggagattamra
superscript
iii
platinum
onestep
qrtpcr
kit
life
technolog
per
manufactur
protocol
previous
describ
method
host
ribosom
rna
rrna
quantifi
sampl
use
abi
taqman
ribosom
rna
primer
probe
follow
manufactur
protocol
life
technolog
ovat
rnaseq
version
system
nugen
san
carlo
ca
viral
rna
amplifi
dsdna
per
manufactur
protocol
briefli
rna
revers
transcrib
cdna
use
oligodt
random
primer
dsdna
gener
amplifi
use
singleprim
isotherm
linear
amplif
spia
previous
describ
follow
modif
perform
first
use
volum
ampur
rna
clean
bead
prior
spia
amplif
second
final
amplifi
product
purifi
use
volum
ampur
xp
bead
beckman
coulter
genom
danver
amplifi
product
elut
te
buffer
life
technolog
technic
replic
perform
hiv
clone
hiv
clinic
sampl
wnv
clone
dilut
sampl
prepar
pairedend
librari
illumina
sequenc
accord
previous
publish
method
ovat
rnaseq
version
reaction
shear
size
select
perform
sinc
major
amplifi
product
bp
ovat
rnaseq
version
reaction
amplifi
product
shear
singl
tube
format
use
adapt
focus
acoust
shear
technolog
machin
covari
woburn
shear
condit
follow
time
second
duti
cycl
intens
cycl
per
burst
mode
frequenc
sweep
shear
sampl
purifi
use
volum
ampur
xp
bead
result
fragment
bp
briefli
librari
prepar
endrepair
product
nugen
reaction
shear
version
follow
abas
addit
adapt
ligat
pcr
follow
modif
made
librari
gener
fork
adapt
contain
uniqu
index
sequenc
number
pcr
cycl
vari
cycl
per
sampl
use
lowest
number
cycl
need
sequenc
pcr
reaction
purifi
use
round
volum
ampur
xp
bead
sequenc
hiv
wnv
index
librari
pool
sampl
hiseq
illumina
hayward
ca
lane
base
pairedend
read
sequenc
rsv
index
librari
pool
two
sampl
miseq
illumina
base
pairedend
read
sequenc
read
bin
index
read
prior
analysi
illumina
read
gener
rna
process
ovat
rnaseq
kit
start
variabl
number
base
deriv
kit
primer
first
base
read
trim
prior
align
analys
input
data
composit
first
employ
effici
illumina
align
align
read
viral
host
refer
genom
hiv
clone
clinic
sampl
refer
genom
use
concaten
human
genom
assembl
human
rrna
sequenc
hiv
sequenc
wnv
clone
sampl
refer
genom
use
concaten
preliminari
unpublish
sequenc
data
golden
hamster
mesocricetu
auratu
k
lindbladtoh
person
commun
hamster
rrna
sequenc
wnv
refer
rsv
clinic
sampl
refer
genom
use
concaten
human
genom
assembl
human
rrna
sequenc
rsv
sequenc
align
carri
first
align
read
independ
use
command
bwa
aln
q
l
k
read
pair
inform
use
invok
command
bwa
samp
mergebamalign
picard
packag
http
picardsourceforgenet
use
return
unmap
read
align
bam
file
custom
script
use
count
number
read
align
concaten
refer
compar
bwa
align
mosaik
align
version
http
bioinformaticsbcedumarthlabmosaik
slower
accur
align
rel
long
illumina
read
like
one
use
current
studi
determin
accur
coverag
inform
viral
sampl
use
mosaik
mosaikalign
st
illumina
hs
act
bw
mmp
minp
align
read
target
viral
refer
genom
consensu
assembl
result
primer
sequenc
trim
sinc
softclip
toler
mosaik
determin
composit
unmap
read
bwa
align
discuss
earlier
carri
taxonom
analysi
unmap
read
use
megan
packag
version
http
wwwabinformatikunituebingendesoftwaremegan
sequenc
hiv
wnv
clone
random
subset
unmap
read
select
align
nt
databas
megablast
v
b
e
result
visual
megan
packag
assembl
illumina
data
use
vicuna
assembl
program
yang
et
al
manuscript
submit
short
vicuna
use
ovat
rnaseq
primer
sequenc
infer
sever
input
dataset
read
trim
low
complex
read
discard
sinc
hiv
rsv
wnv
dataset
contain
larg
percentag
read
deriv
host
invok
option
target
genom
filter
compon
vicuna
base
sequenc
similar
remain
read
cluster
form
contig
valid
read
contig
suffici
similar
compar
consensu
guid
pair
read
contig
compar
use
effici
align
algorithm
two
contig
share
signific
overlap
merg
assembl
process
termin
merg
could
appli
sever
case
viral
refer
genom
use
extend
assembl
briefli
raw
contig
base
obtain
assembl
align
refer
use
muscl
version
contig
broken
segment
delet
nucleotid
compar
refer
contig
ad
form
final
assembl
decreas
order
length
either
whole
assembl
cover
contig
remain
overlap
segment
merg
togeth
concaten
nucleotid
sequenc
segment
central
posit
overlap
comparison
assembl
perform
custom
script
first
align
use
muscl
version
calcul
percent
ident
target
region
script
calcul
composit
ident
ie
posit
consensu
base
either
match
found
nondomin
variant
sampl
compar
nucleotid
frequenc
tabl
use
align
match
posit
consensu
genom
assembl
gener
part
project
submit
ncbi
genbank
databas
access
number
illumina
read
data
submit
ncbi
short
read
archiv
trace
identifi
gener
illumina
librari
hiv
rsv
wnv
sampl
use
ovat
rnaseq
system
viral
sampl
contain
ag
fg
copi
viral
rna
concentr
extract
rna
could
quantifi
use
standard
rna
quantif
method
therefor
quantiti
viral
genom
extract
determin
viralspecif
qrtpcr
assay
supplementari
tabl
sampl
amount
host
rna
determin
rrna
qrtpcr
assay
supplementari
tabl
use
illumina
sequenc
ensur
obtain
suffici
coverag
compens
high
level
host
contamin
discuss
later
clinic
sampl
use
ovat
rnaseq
version
system
hiv
clone
clinic
sampl
input
amount
viral
reaction
minimum
recommend
amount
pg
rna
evalu
success
amplif
reaction
use
hivspecif
qpcr
assay
supplementari
tabl
wnv
clone
sampl
ovat
rnaseq
version
system
reaction
perform
use
copi
input
rna
technic
duplic
success
amplif
reaction
determin
use
wnvspecif
qpcr
assay
supplementari
tabl
rsv
clinic
sampl
ovat
rnaseq
version
system
reaction
perform
use
copi
input
rna
success
amplif
reaction
determin
use
rsvspecif
qpcr
assay
amplif
reaction
gener
suffici
final
product
make
illumina
librari
illumina
librari
gener
pool
sequenc
obtain
million
read
per
librari
supplementari
tabl
determin
origin
illumina
read
align
read
host
rrna
viral
refer
hiv
clone
sampl
major
read
align
hiv
refer
less
read
align
host
tabl
supplementari
tabl
hiv
clinic
sampl
percent
hiv
align
read
significantli
lower
major
read
align
host
tabl
supplementari
tabl
percent
read
align
hiv
higher
version
version
sampl
tabl
supplementari
tabl
result
higher
averag
coverag
cd
version
version
versu
respect
tabl
supplementari
tabl
wnv
clone
sampl
read
align
wnv
refer
align
host
tabl
supplementari
tabl
averag
coverag
cd
wnv
sampl
tabl
supplementari
tabl
rsv
clinic
sampl
percent
rsv
align
read
wherea
major
read
align
host
tabl
supplementari
tabl
averag
coverag
cd
rsv
sampl
analys
read
data
identifi
sever
type
artifact
ovat
rnaseq
system
first
major
read
contain
partial
bp
ovat
rnaseq
spia
singl
primer
isotherm
amplif
primer
often
appear
start
read
second
substanti
fraction
read
align
viral
host
refer
fraction
unalign
read
use
megan
identifi
composit
unalign
read
hiv
wnv
clone
supplementari
figur
hiv
clone
read
composit
bacteri
eukaryot
retroviru
assign
hit
retroviru
hit
unalign
hiv
sequenc
major
assign
read
bacteri
rrna
hiv
hit
could
classifi
specif
taxonom
group
hit
read
mostli
simpl
sequenc
repeat
spia
primer
sequenc
high
abund
read
might
due
low
input
amount
led
greater
abund
nonspecif
byproduct
wnv
clone
read
composit
bacteri
eukaryot
flaviviru
assign
hit
eukaryot
hit
mostli
rat
mous
flaviviru
hit
unalign
wnv
sequenc
hit
wnv
clone
simpl
sequenc
repeat
spia
primer
major
hit
read
wnv
could
identifi
similar
known
sequenc
possibl
read
could
hamsterspecif
sequenc
align
preliminari
golden
hamster
assembl
determin
whether
method
captur
entir
target
region
cd
read
align
cd
viral
refer
use
mosaik
align
tool
hiv
clone
clinic
sampl
reproduc
coverag
entir
cd
obtain
figur
case
complet
coverag
obtain
supplementari
figur
previou
report
use
system
util
version
system
compar
coverag
pattern
version
version
system
hiv
clone
clinic
sampl
figur
hiv
clone
clinic
sampl
version
even
coverag
version
figur
base
lower
coeffici
variat
cv
supplementari
tabl
even
coverag
highli
desir
sequenc
viral
sampl
applic
therefor
version
system
would
prefer
system
next
assess
read
coverag
serial
dilut
wnv
clone
rel
wnv
refer
method
captur
entir
wnv
cd
littl
copi
input
rna
figur
dilut
wnv
clone
rna
complet
coverag
obtain
supplementari
figur
addit
pattern
variabl
coverag
reproduc
wnv
clone
input
amount
rang
copi
supplementari
figur
final
assess
read
coverag
two
rsv
clinic
sampl
method
captur
entir
rsv
cd
sampl
supplementari
figur
similarli
hiv
wnv
sampl
coverag
variabl
across
cd
due
challeng
larg
amount
host
contamin
highli
variabl
coverag
presenc
spia
primer
found
sequenc
data
use
newli
develop
assembl
vicuna
gener
de
novo
assembl
hiv
rsv
wnv
low
input
sampl
yang
et
al
manuscript
submit
vicuna
design
assembl
genet
heterogen
viral
genom
presenc
larg
amount
host
contamin
enabl
direct
comparison
among
viral
librari
randomli
sampl
million
read
sampl
choic
reflect
realist
sequenc
process
product
allow
us
obtain
high
averag
coverag
eg
target
region
well
suffici
coverag
across
genom
given
read
nonvir
sequenc
coverag
uneven
hiv
clinic
sampl
gener
consensu
sequenc
cover
target
region
tabl
clinic
sampl
gener
consensu
sequenc
cover
target
region
supplementari
tabl
wnv
clone
sampl
gener
consensu
sequenc
cover
target
region
tabl
wnv
sampl
gener
consensu
sequenc
cover
target
region
supplementari
tabl
rsv
clinic
sampl
gener
consensu
sequenc
cover
target
region
tabl
select
sampl
hiv
wnv
rsv
compar
assembl
statist
three
differ
assembl
vicuna
soapdenovo
supplementari
tabl
vicuna
outperform
assembl
return
fewer
longer
contig
cover
larger
part
cd
percent
cd
cover
contig
could
calcul
soapdenovo
due
larg
number
short
contig
would
requir
second
assembl
order
reconstitut
consensu
sequenc
assembl
process
observ
sever
case
invok
option
refer
guid
merg
compon
vicuna
initi
assembl
could
improv
final
consensu
major
clinic
sampl
assembl
one
two
contig
prior
refer
guid
merg
signific
portion
viral
genom
assembl
singl
larg
contig
supplementari
tabl
without
need
refer
guid
merg
refer
guid
merg
increas
coverag
final
cd
viral
genom
tabl
supplementari
tabl
addit
upon
investig
discov
artifact
produc
chimer
fragment
might
caus
stem
loop
rna
secondari
structur
supplementari
figur
artifact
complic
de
novo
assembl
increas
number
contig
requir
refer
guid
merg
contig
next
compar
consensu
assembl
technic
replic
hiv
clone
clinic
sampl
tabl
first
compar
nucleotid
differ
replic
assembl
ident
tabl
hiv
clone
replic
assembl
ident
hiv
clinic
sampl
b
assembl
ident
copi
replic
respect
wnv
clone
replic
assembl
ident
copi
replic
respect
discrep
assembl
consensu
sequenc
may
either
caus
differ
data
gener
assembl
process
evalu
reproduc
method
examin
nucleotid
composit
differ
tabl
two
assembl
mismatch
residu
consensu
base
first
assembl
consid
consist
consensu
base
second
assembl
mismatch
support
read
align
second
assembl
composit
mismatch
tabl
hiv
clone
replic
assembl
ident
includ
read
support
differ
assembl
hiv
clinic
sampl
b
assembl
ident
copi
replic
respect
wnv
clone
replic
assembl
ident
copi
replic
thu
assembl
hiv
wnv
consensu
sequenc
reproduc
point
comparison
newli
develop
method
attempt
gener
rtpcr
amplicon
hiv
clone
clinic
sampl
b
sequenc
use
previous
describ
method
clinic
sampl
b
abl
gener
fouroverlap
pcr
amplicon
span
cd
four
attempt
newli
develop
method
sampl
success
six
attempt
gener
consensu
assembl
cover
cd
supplementari
tabl
gener
fouroverlap
pcr
amplicon
sequenc
built
consensu
assembl
hiv
clone
clinic
sampl
hiv
clone
assembl
ident
two
method
tabl
clinic
sampl
assembl
ident
nucleotid
composit
level
respect
tabl
newli
develop
method
gener
assembl
hiv
clone
clinic
sampl
highli
similar
gener
use
standard
rtpcr
method
studi
use
sequenceindepend
amplif
method
coupl
illumina
sequenc
gener
full
genom
assembl
hiv
rsv
wnv
sampl
littl
viral
rna
genom
previou
studi
use
ovat
rnaseq
hiv
viral
rna
use
ex
vivo
amplif
larg
amount
viral
rna
util
referencebas
assembl
approach
sever
reason
condit
ideal
sequenc
clinic
sampl
first
clinic
sampl
contain
picogram
less
viral
rna
studi
abl
studi
viral
sampl
femtogram
attogram
amount
viral
rna
million
time
less
materi
previous
use
input
ovat
rnaseq
system
gener
suffici
dsdna
illumina
sequenc
second
ex
vivo
amplif
labori
could
lead
bia
sampl
gener
day
cultur
abl
captur
complet
sequenc
coverag
cd
directli
clinic
sampl
therefor
gener
sequenc
data
repres
domin
viral
genom
within
infect
individu
third
util
recent
develop
de
novo
genom
assembl
algorithm
vicuna
assembl
fulllength
consensu
yang
et
al
manuscript
submit
previou
studi
shown
de
novo
assembl
significantli
improv
accuraci
assembl
util
data
compar
referencebas
assembl
approach
studi
vicuna
outperform
altern
assembl
supplementari
tabl
return
fewest
longest
contig
method
like
sequenceindepend
method
gener
highli
variabl
coverag
across
viral
genom
rna
virus
larg
number
function
rna
secondari
structur
result
stall
cdna
synthesi
uneven
coverag
may
due
viral
secondari
structur
vicuna
assembl
abl
work
highli
variabl
coverag
gener
fulllength
consensu
assembl
hiv
rsv
wnv
sampl
studi
abl
use
ovat
rnaseq
method
quantifi
amount
viral
rna
amount
clinic
sampl
rsv
hiv
clinic
sampl
clinic
sampl
highest
input
viral
rna
amount
highest
percent
read
align
viral
refer
supplementari
tabl
correl
input
rna
viral
sequenc
coverag
method
may
provid
approxim
viral
amount
clinic
sampl
quantit
major
disadvantag
sequenceindepend
amplif
viral
rna
sampl
larg
amount
host
contamin
amplifi
use
method
test
sever
differ
rna
sequenceindepend
amplif
kit
evalu
util
viral
clinic
sampl
unpublish
result
transplex
whole
transcriptom
amplif
aldrich
st
loui
mo
complet
transplex
whole
transcriptom
amplif
aldrich
smarter
cdna
synthesi
clontech
mountain
view
ca
kit
produc
fewer
read
align
hiv
genom
clinic
sampl
compar
ovat
rnaseq
system
c
malboeuf
unpublish
data
ovat
rnaseq
system
perform
best
part
due
lowest
percent
read
align
host
contamin
particularli
rrna
compris
total
rna
ovat
rnaseq
experi
total
read
hiv
rsv
clinic
sampl
align
rrna
tabl
signific
reduct
amplif
rrna
may
led
increas
amplif
viral
rna
thu
allow
us
util
million
read
gener
fulllength
consensu
assembl
averag
coverag
method
sever
advantag
standard
rtpcr
base
method
requir
prior
viral
sequenc
knowledg
primer
design
enabl
studi
virus
limit
sequenc
data
lack
viralspecif
primer
allow
identif
viral
recombin
might
found
standard
rtpcr
method
method
capabl
amplifi
viral
rna
genom
success
tradit
rtpcr
method
hiv
clinic
sampl
b
four
rtpcr
attempt
success
captur
cd
six
attempt
method
cd
captur
tabl
furthermor
method
easili
applic
multipl
sampl
type
appli
method
hiv
rsv
wnv
sampl
without
need
optim
develop
robust
rtpcr
process
viral
specif
primer
requir
signific
effort
sever
month
unpublish
result
method
potenti
speed
viral
genom
sequenc
project
method
work
highli
variabl
viru
entir
cd
genom
start
viral
genom
tabl
addit
process
viral
rna
dsdna
requir
hour
furthermor
method
coupl
nextera
illumina
librari
construct
one
could
gener
illumina
librari
less
singl
day
although
nextera
method
fast
transposasebas
method
illumina
librari
construct
may
introduc
gcbia
compar
standard
method
million
read
necessari
assembl
complet
viral
genom
miseq
ion
torrent
sequenc
could
use
would
allow
research
go
sampl
sequenc
data
less
week
final
ovat
rnaseq
method
avail
autom
format
allow
highthroughput
process
clinic
sampl
million
read
need
per
sampl
one
could
pool
sampl
per
lane
method
describ
sever
promis
applic
sequenceindepend
amplif
method
coupl
de
novo
assembl
viral
genom
provid
new
methodolog
sequenc
viral
genom
mani
differ
sampl
type
method
gener
nextgener
sequenc
data
pathogen
allow
greater
insight
pathogen
evolut
fit
emerg
transmiss
well
factor
import
develop
new
therapeut
vaccin
addit
method
could
use
discov
known
unknown
pathogen
clinic
sampl
limit
virus
likewis
method
could
also
use
surveil
detect
viral
rna
environment
sourc
wnv
mosquito
sampl
surveil
abil
could
provid
valuabl
insight
pathogen
circul
provid
earli
warn
futur
outbreak
addit
one
would
abl
identifi
studi
multipl
virus
singl
sampl
could
benefici
understand
dynam
viral
coinfect
hivhcv
furthermor
method
could
appli
parasit
bacteri
fungal
pathogen
discoveri
sequenc
total
rna
contain
express
pathogen
rna
express
pathogen
could
discov
incident
rnaseq
data
addit
may
cost
effect
project
sequenc
rna
rather
dna
detect
pathogen
greater
sequenc
depth
may
need
dna
rna
morin
et
al
demonstr
capabl
detect
express
pathogen
rna
rna
sequenc
summari
demonstr
method
reproduc
robust
gener
full
length
genom
challeng
ultralow
copi
viral
rna
sampl
demonstr
success
hiv
rsv
wnv
sampl
method
appli
viral
sampl
variou
viral
rna
amount
host
contamin
supplementari
data
avail
nar
onlin
supplementari
tabl
supplementari
figur
nation
institut
allergi
infecti
diseas
nation
institut
health
depart
health
human
servic
contract
grant
tma
bill
melinda
gate
foundat
tma
mrh
fund
open
access
charg
niaid
contract
conflict
intertest
statement
develop
lab
method
initi
sequenc
result
obtain
april
joshua
levin
particip
one
day
medicinalclin
sequenc
technolog
advanc
summit
nugen
compens
time
travel
expens
